4//SEC Filing
Kirpekar Sahil 4
Accession 0001140361-25-010116
CIK 0001840904other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 9:00 PM ET
Size
4.5 KB
Accession
0001140361-25-010116
Insider Transaction Report
Form 4
Kirpekar Sahil
Chief Business Officer
Transactions
- Sale
Common Shares
2025-03-21$1.35/sh−48,563$65,560→ 115,636 total
Footnotes (1)
- [F1]Represents shares sold to satisfy the Reporting Person's tax liability on vesting of restricted stock units.
Documents
Issuer
ATAI Life Sciences N.V.
CIK 0001840904
Entity typeother
Related Parties
1- filerCIK 0001951712
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 9:00 PM ET
- Size
- 4.5 KB